Get the Pulse on Biotech Policy and Investment Trends
BIO's business and therapeutic panel discussions, plus Fireside Chats with biopharma leaders, provide insights on issues essential to the industry and provide a wealth of information of strategic relevance to help your organization succeed.
Join us for two-days of interactive and on demand sessions covering a mix of therapeutic areas, business development, digital health, patient advocacy, public policy, and next generation biotherapeutics, along with added content relevant to industry responses to COVID-19.
Sessions will remain available on demand for a period of at least 30 days after the start of the event.
- Progress in Drugging the Undruggable Cancer Targets
- SPACs: Criteria for Successful Launches
- Reverse Trend: China’s Shift to a Center for Innovation
- Deal Making in the Next Decade: Lessons Learned and Planning for Tomorrow
- CRISPR’s Progress for Patients: Clinical Development of Therapies
- Policy Scenarios on Investor’s Reactions to Reference Pricing Models
- Policy Outlook: Reviewing the Pathway for Advancing Biopharma Goals in the Congress and White House
- Turning RNA Research into Medicines
- Market Outlook: Breaking Records or Expecting an Adjustment